Planta Med 2016; 82(04): 285-288
DOI: 10.1055/s-0035-1558208
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Effectiveness of Topical Nigella sativa Seed Oil in the Treatment of Cyclic Mastalgia: A Randomized, Triple-Blind, Active, and Placebo-Controlled Clinical Trial

Hasan Fallah Huseini
1   Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran
,
Saeed Kianbakht
1   Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran
,
Mohammad Hossein Mirshamsi
2   Department of Surgery, Faculty of Medicine, Yazd University of Medical Sciences, Yazd, Iran
,
Ali Babaei Zarch
3   Department of Pharmacology, Faculty of Pharmacy, Yazd University of Medical Sciences, Yazd, Iran
› Author Affiliations
Further Information

Publication History

received 07 July 2015
revised 27 September 2015

accepted 05 October 2015

Publication Date:
19 November 2015 (online)

Abstract

Cyclic mastalgia is common in women and has no optimal therapy. Analgesic effects of Nigella sativa have been reported. Thus, the effect of a standardized N. sativa seed oil (600 mg applied to the site of pain bis in die for 2 months) on the 10-centimeter visual analog scale scores of pain severity in 52 women with cyclic mastalgia was compared to that of topical diclofenac (20 mg bis in die) (n = 51) and placebo (n = 53). There was no significant difference between the 1- and 2-month pain scores in the active treatment groups (p > 0.05). The pain scores of the active treatment groups did not differ significantly at 1 and 2 months (p > 0.05). The endpoint pain scores of the active treatment groups decreased significantly compared with the baseline (both p < 0.001). The pain scores of the active treatment groups at 1 and 2 months were significantly smaller than those of the placebo group (both p < 0.001). The pain scores of the placebo group at 1 and 2 months were not significantly different from the baseline (p > 0.05). No adverse effect was observed. In conclusion, topical N. sativa seed oil is safe, more effective than placebo, and has clinical effectiveness comparable to topical diclofenac in the treatment of cyclic mastalgia.

 
  • References

  • 1 Amin AL, Purdy AC, Mattingly JD, Kong AL, Termuhlen PM. Benign breast disease. Surg Clin North Am 2013; 93: 299-308
  • 2 Onstad M, Stuckey A. Benign breast disorders. Obstet Gynecol Clin North Am 2013; 40: 459-473
  • 3 Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc 2004; 79: 353-372
  • 4 Gumm R, Cunnick GH, Mokbel K. Evidence for the management of mastalgia. Curr Med Res Opin 2004; 20: 681-684
  • 5 Carmichael AR. Can Vitex Agnus castus be used for the treatment of mastalgia? What is the current evidence?. Evid Based Complement Alternat Med 2008; 5: 247-250
  • 6 Olawaiye A, Withiam-Leitch M, Danakas G, Kahn K. Mastalgia: a review of management. J Reprod Med 2005; 50: 933-939
  • 7 Iddon J, Dixon JM. Mastalgia. BMJ 2013; 347: f3288
  • 8 Scurr J, Hedger W, Morris P, Brown N. The prevalence, severity, and impact of breast pain in the general population. Breast J 2014; 20: 508-513
  • 9 Kataria K, Dhar A, Srivastava A, Kumar S, Goyal A. A systematic review of current understanding and management of mastalgia. Indian J Surg 2014; 76: 217-222
  • 10 Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa . Phytother Res 2003; 17: 299-305
  • 11 Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, Damanhouri ZA, Anwar F. A review on therapeutic potential of Nigella saitva: A miracle herb. Asian Pac J Trop Biomed 2013; 3: 337-352
  • 12 Abdel-Fattah AM, Matsumoto K, Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol 2000; 400: 89-97
  • 13 Ringbom T, Huss U, Stenholm Å, Flock S, Skattebøl L, Perera P, Bohlin L. Cox-2 inhibitory effects of naturally occurring and modified fatty acids. J Nat Prod 2001; 64: 745-749
  • 14 Cavalcante Melo FH, Rios ER, Rocha NF, Citó Mdo C, Fernandes ML, de Sousa DP, de Vasconcelos SM, de Sousa FC. Antinociceptive activity of carvacrol (5‐isopropyl‐2‐methylphenol) in mice. J Pharm Pharmacol 2012; 64: 1722-1729
  • 15 Millet AV, Dirbas FM. Clinical management of breast pain: a review. Obstet Gynecol Surv 2002; 57: 451-461
  • 16 Irving AD, Morrison SL. Effectiveness of topical non-steroidal anti-inflammatory drugs in the management of breast pain. J R Coll Surg Edinb 1998; 43: 158-159
  • 17 Colak T, Ipek T, Kanik A, Ogetman Z, Aydin S. Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg 2003; 196: 525-530
  • 18 Qureshi S, Sultan N. Topical nonsteroidal anti-inflammatory drugs versus oil of evening primrose in the treatment of mastalgia. Surgeon 2005; 3: 7-10
  • 19 Ahmadinejad M, Delfan B, Haghdani S, Hashemi M, Khan IA, Tafti MT. Comparing the effect of diclofenac gel and piroxicam gel on mastalgia. Breast J 2010; 16: 213-214
  • 20 Barkin RL. The pharmacology of topical analgesics. Postgrad Med 2013; 125: 7-18
  • 21 Duchateau GSMJE, van Oosten HJ, Vasconcellos MA. Analysis of cis-and trans-fatty acid isomers in hydrogenated and refined vegetable oils by capillary gas-liquid chromatography. J Am Oil Chem Soc 1996; 73: 275-282
  • 22 McLafferty FW, Stauffer DB. The Wiley/NBS Registry of Mass Spectral Data. New York: Wiley & Sons; 1989
  • 23 Adams RP. Identification of essential oil components by gas chromatography/quadrupole mass spectrometry, 4th edition. Carol Stream, IL: Allured Publishing Corporation; 2007: 22-25